Advisory committee members of the Master of Science in Biomedical Regulatory Affairs program represent a cross section of the professional community and include representatives from medical product manufacturers, research institutions and the FDA. Committee members help guide course design and review course content to ensure the program remains current as the field evolves.
James Cross, Senior Director, Regulatory Affairs, Forty Seven Inc.
Scott Dennis, Vice President, Regulatory & Quality Affairs, Bio-Rad Laboratories
Jill Herendeen, Senior Director, Regulatory Affairs, Pharmacyclics
Lena Huerlimann, Regulatory, Quality and ISO Audit Consultant
Ed Kelly, Associate Professor, Department of Pharmaceutics, University of Washington
Tina Kim-Hafken, Associate Director, Seattle Genetics
Marcia Koren, Proprietor, GCP Compliance Consulting
Paula Lank, Vice-President, Regulatory & Clinical Affairs, Physio-Control
Robert Mackey, Regulatory Director and Regional Manager, Harris Group
Artha Nafie, Senior Quality Manager, Philips (Heartstream)
Andy Walker, Senior Vice President, Manufacturing, Juno Therapeutics
Roberta Wong, Principal Strategist, Wong & Associates, and Affiliate Assistant Professor, Department of Bioengineering
Jeff Yuen, President, Jeff Yuen & Associates